Current:Home > MyCOVID variant BA.2.86 triples in new CDC estimates, now 8.8% of cases -ProsperPlan Hub
COVID variant BA.2.86 triples in new CDC estimates, now 8.8% of cases
View
Date:2025-04-25 01:54:30
Nearly 1 in 10 new COVID-19 cases in the U.S. are from the BA.2.86 variant, the Centers for Disease Control and Prevention estimated Monday, nearly triple what the agency estimated the highly mutated variant's prevalence was two weeks ago.
Among the handful of regions with enough specimens reported from testing laboratories, BA.2.86's prevalence is largest in the Northeast: 13.1% of cases in the New York and New Jersey region are blamed on the strain.
Monday's figures mark the first time BA.2.86's prevalence has surged enough to be listed as a standalone variant on the CDC's estimates. Scientists first warned of the highly mutated strain's discovery over the summer.
"In previous Nowcast updates, BA.2.86 was too uncommon to be shown separately and was grouped with other BA.2 strains," the CDC said Monday.
Before this point, officials have said the vast majority of new COVID-19 cases have been blamed on the XBB variant and a crowd of XBB's closely related descendants. Those include the HV.1 and EG.5 variants that are currently predominant nationwide.
The CDC's estimates carry wide margins of error around BA.2.86's prevalence. As little as 4.8% or as much as 15.2% of circulating SARS-CoV-2 could be from BA.2.86, the agency says.
However, this latest estimate – 8.8% through Nov. 25 – is virtually triple what it was on Nov. 11, when 3.0% of new cases were estimated to be BA.2.86. The CDC typically publishes its variant estimates every other Friday, but had delayed last week's release until after the Thanksgiving holiday weekend.
"It is important to note that early projections tend to be less reliable, since they depend on examining growth trends of a smaller number of sequences, especially as laboratory-based testing volume for SARS-CoV-2 has decreased substantially over time," the agency said.
The World Health Organization also recently stepped up its classification of BA.2.86 and its descendants to a "variant of interest" after a rise in cases from the strain.
Early data on BA.2.86 suggests it does not appear to lead to worse or different symptoms than previous strains, the WHO said in its Nov. 21 risk evaluation, but noted a "substantial rise" in recent BA.2.86 reports.
The CDC said it did not disagree with the WHO's assessment that BA.2.86 likely posed a "low" public health risk, adding that for now the strain "BA.2.86 does not appear to be driving increases in infections or hospitalizations in the United States."
It comes as the CDC has begun to track a renewed increase in indicators tracking COVID-19's spread across the U.S. headed into the winter.
After weeks of largely slowing or flat trends, the CDC said this month that figures like emergency department visits had begun to increase nationwide from COVID-19. Virtually all regions of the country are now seeing at least slight increases.
Some of the highest increases are in the Midwestern region covering Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin, where trends are nearing levels not seen since early January.
Is the JN.1 variant to blame?
Since August, BA.2.86's broad array of mutations did not appear to be enough for the strain to gain a foothold over XBB and its descendants. Months of the highly mutated variant's spread only resulted in a small share of cases throughout the world.
But scientists in recent weeks have been studying a steep increase in a BA.2.86 descendant called JN.1, which quickly rose to become the fastest-growing subvariant worldwide.
Many cases have been reported in Europe, which has seen increasing cases from BA.2.86 and its descendants.
Authorities in France said on Nov. 13 that JN.1 was largely driving that country's increase in BA.2.86 infections, climbing to 10% of sequences in the country. Early investigations of JN.1 had not turned up any worrying signals so far compared to other BA.2.86 infections, they said, though more in-depth analyses were underway.
Data from recent weeks tallied from the GISAID virus database suggests as much as a third of COVID-19 variants reported from labs in the U.S. have been of JN.1.
"Currently, JN.1 is the most common version of BA.2.86 in the U.S. CDC projects BA.2.86 and its offshoots like JN.1 will continue to increase as a proportion of SARS-CoV-2 genomic sequences," CDC spokesperson Jasmine Reed told CBS News in an email.
Last month, the CDC said it expected COVID-19 tests and treatment would remain effective against JN.1, which is closely related to BA.2.86 aside from a single change to its spike protein that early research suggests is enabling it to spread faster.
This season's vaccines are also expected to work against JN.1 similar to what was estimated for its BA.2.86 parent, the agency said.
- In:
- COVID-19
- Coronavirus
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19.
TwitterveryGood! (24)
Related
- California DMV apologizes for license plate that some say mocks Oct. 7 attack on Israel
- News anchor carried the secret of her mother’s murder as Vermont police investigated
- Elon Musk, X Corp. threatens lawsuit against anti-hate speech group
- Ex-millionaire who had ties to corrupt politicians gets 5-plus years in prison for real estate fraud
- Meet first time Grammy nominee Charley Crockett
- Suspect in Gilgo Beach murders due in court
- Bo Bichette slams on brakes, tweaks right knee on basepaths
- Connecticut US Rep. Rosa DeLauro gets inked at age 80 alongside her 18-year-old granddaughter
- The company planning a successor to Concorde makes its first supersonic test
- Josh Stein’s gubernatorial campaign says it lost $50,000 through scam that targeted vendor
Ranking
- What were Tom Selleck's juicy final 'Blue Bloods' words in Reagan family
- Churchill Downs to resume races after announcing new safety measures for horses and riders
- Clippers’ Amir Coffey arrested on suspicion of carrying a concealed firearm in a vehicle, police say
- CVS to lay off 5,000 employees as it slashes costs
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- Euphoria Creator Sam Levinson Reflects on Special Angus Cloud's Struggles Following His Death
- CVS to lay off 5,000 employees as it slashes costs
- Leprosy could be endemic in Central Florida, CDC says. What to know about the disease.
Recommendation
Former Danish minister for Greenland discusses Trump's push to acquire island
Netflix faces off with creators, advertises for a $900,000 A.I. product manager
5 people died in a fiery wrong-way crash in middle Georgia
What does 'lmk' mean? This is the slang's definition and how to use it correctly.
Federal Spending Freeze Could Have Widespread Impact on Environment, Emergency Management
Helicopter crashes into cornfield in southern Illinois, killing pilot
Here’s What Sofía Vergara Requested in Response to Joe Manganiello’s Divorce Filing
Trump's push to block GA probe into 2020 election rejected, costly Ukraine gains: 5 Things podcast